Human ISPD Is a Cytidyltransferase Required for Dystroglycan O-Mannosylation
- 1 December 2015
- journal article
- Published by Elsevier in Chemistry & Biology
- Vol. 22 (12) , 1643-1652
Abstract
No abstract availableKeywords
Funding Information
- Prinses Beatrix Spierfonds (W.OR09-15)
- Nederlands Organisation for Scientific Research (40-00506-98-9001, 91713359)
- Grant-in-Aid for Scientific Research on Innovative Areas (26110727)
- AbbVie
- Boehringer Ingelheim
- Canada Foundation for Innovation
- Canadian Institutes for Health Research
- Genome Canada
- GlaxoSmithKline
- Janssen
- Lilly Canada
- Novartis Research Foundation
- Ontario Ministry of Economic Development and Innovation
- Pfizer
- Takeda
- Wellcome Trust (092809/Z/10/Z)
This publication has 44 references indexed in Scilit:
- Dystroglycan Organizes Axon Guidance Cue Localization and Axonal PathfindingNeuron, 2012
- Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of α-dystroglycanNature Genetics, 2012
- ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndromeNature Genetics, 2012
- A transcription activator-like effector toolbox for genome engineeringNature Protocols, 2012
- Ebola virus entry requires the cholesterol transporter Niemann–Pick C1Nature, 2011
- A Dystroglycan Mutation Associated with Limb-Girdle Muscular DystrophyNew England Journal of Medicine, 2011
- SRD5A3 Is Required for Converting Polyprenol to Dolichol and Is Mutated in a Congenital Glycosylation DisorderCell, 2010
- Deficiency of Dol-P-Man Synthase Subunit DPM3 Bridges the Congenital Disorders of Glycosylation with the DystroglycanopathiesThe American Journal of Human Genetics, 2009
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D Structural Biology, 2004
- Post-translational disruption of dystroglycan–ligand interactions in congenital muscular dystrophiesNature, 2002